Cartier Iron Provides Financing Update
TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — Cartier Iron Corporation (CSE: CFE) (“Cartier Iron” or the “Company”), is pleased to […]
Equillium Announces Successful Completion of FDA Pre-IND Meeting Enabling Advancement of Itolizumab into a Potential Registration Study as a Treatment for Hospitalized COVID-19 Patients
Equillium anticipates filing a U.S. IND for Itolizumab for COVID-19 and initiating a global Phase 3 clinical study in Q4 […]
WeedMD Advances Strategic Growth Initiatives in the Adult-Use Market with New Color Cannabis Offerings
TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or the “Company”), a federally-licensed producer and […]
TSX News -
Cardinal Directors Accept Shandong Gold Takeover Offer
TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — Cardinal Resources Limited (ASX/TSX: CDV) (“Cardinal” or “Company”) advises that in accordance with […]
Cerence Expands into the Global Two-Wheeler Market; Signs Agreement with 70mai, a member of the Xiaomi MiOT Ecosystem, for its New Smart Electric Scooter
BURLINGTON, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, has expanded […]
Kratos Announces Space Domain Awareness Services to Assess Spacecraft Orbiting in Close Proximity to Each Other
SAN DIEGO, Sept. 15, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security […]
Gritstone Oncology Announces Updated Presentation Time at Cantor Virtual Global Healthcare Conference
EMERYVILLE, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next […]
AzurRx BioPharma Announces Two Abstracts Accepted for Presentation at the 2020 North American Cystic Fibrosis Virtual Conference
Abstracts to Focus on:Results from Phase 2, Open-Label, Multicenter, 2×2 Cross-Over Trial to Assess Safety and Efficacy of MS1819 in […]
Momenta Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Proposed Sale to Johnson & Johnson
CAMBRIDGE, Mass., Sept. 15, 2020 (GLOBE NEWSWIRE) — Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA, “Momenta” or the “Company”), a biotechnology company focused […]
UNITY Biotechnology Announces Actions to Focus on Senolytic Programs in Ophthalmology and Neurology
– Corporate restructuring to extend cash runway through mid-2022 and key milestones –– UBX1325 to enter clinical development in patients […]
